These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27915184)

  • 1. Anti-atherosclerotic effects of pravastatin in brachiocephalic artery in comparison with en face aorta and aortic roots in ApoE/LDLR
    Kostogrys RB; Franczyk-Zarow M; Gasior-Glogowska M; Kus E; Jasztal A; Wrobel TP; Baranska M; Czyzynska-Cichon I; Drahun A; Manterys A; Chlopicki S
    Pharmacol Rep; 2017 Feb; 69(1):112-118. PubMed ID: 27915184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of Atherogenic Effects of Low Carbohydrate, High Protein Diet (LCHP) in ApoE/LDLR-/- Mice.
    Kostogrys RB; Johann C; Czyżyńska I; Franczyk-Żarów M; Drahun A; Maślak E; Jasztal A; Gajda M; Mateuszuk Ł; Wrobel TP; Baranska M; Wybrańska I; Jezkova K; Nachtigal P; Chlopicki S
    J Nutr Health Aging; 2015 Aug; 19(7):710-8. PubMed ID: 26193853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low carbohydrate, high protein diet promotes atherosclerosis in apolipoprotein E/low-density lipoprotein receptor double knockout mice (apoE/LDLR(-/-)).
    Kostogrys RB; Franczyk-Żarów M; Maślak E; Gajda M; Mateuszuk L; Jackson CL; Chłopicki S
    Atherosclerosis; 2012 Aug; 223(2):327-31. PubMed ID: 22771189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Low Carbohydrate High Protein (LCHP) diet on atherosclerotic plaque phenotype in ApoE/LDLR-/- mice: FT-IR and Raman imaging.
    Wrobel TP; Marzec KM; Chlopicki S; Maślak E; Jasztal A; Franczyk-Żarów M; Czyżyńska-Cichoń I; Moszkowski T; Kostogrys RB; Baranska M
    Sci Rep; 2015 Sep; 5():14002. PubMed ID: 26391802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
    Park KY; Heo TH
    Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of lipids in atherosclerotic lesion in aorta from ApoE/LDLR-/- mice by FT-IR spectroscopy and Hierarchical Cluster Analysis.
    P Wrobel T; Mateuszuk L; Chlopicki S; Malek K; Baranska M
    Analyst; 2011 Dec; 136(24):5247-55. PubMed ID: 22007352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement).
    Teupser D; Persky AD; Breslow JL
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1907-13. PubMed ID: 12907460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pravastatin inhibits plaque rupture and subsequent thrombus formation in atherosclerotic rabbits with hyperlipidemia.
    Wu G; Xie Q; Xu L; Jiang H; Huang Z; Huang C
    Chem Pharm Bull (Tokyo); 2013; 61(2):121-4. PubMed ID: 23207681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet.
    Ma Y; Wang W; Zhang J; Lu Y; Wu W; Yan H; Wang Y
    PLoS One; 2012; 7(4):e35835. PubMed ID: 22558236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pravastatin attenuates interferon-gamma action via modulation of STAT1 to prevent aortic atherosclerosis in apolipoprotein E-knockout mice.
    Zhou XX; Gao PJ; Sun BG
    Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):373-9. PubMed ID: 19018808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL.
    Qin W; Lu Y; Zhan C; Shen T; Dou L; Man Y; Wang S; Xiao C; Bian Y; Li J
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):23-30. PubMed ID: 22038096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root.
    Teupser D; Pavlides S; Tan M; Gutierrez-Ramos JC; Kolbeck R; Breslow JL
    Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17795-800. PubMed ID: 15596719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol effects on endoglin and its downstream pathways in ApoE/LDLR double knockout mice.
    Strasky Z; Vecerova L; Rathouska J; Slanarova M; Brcakova E; Kudlackova Z; Andrys C; Micuda S; Nachtigal P
    Circ J; 2011; 75(7):1747-55. PubMed ID: 21576826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCN4 (WISP-1) reduces apoptosis and atherosclerotic plaque burden in an ApoE mouse model.
    Williams H; Simmonds S; Bond A; Somos A; Li Z; Forbes T; Bianco R; Dugdale C; Brown Z; Rice H; Herman A; Johnson J; George S
    Atherosclerosis; 2024 Oct; 397():118570. PubMed ID: 39276419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiatherosclerotic Effects of 1-Methylnicotinamide in Apolipoprotein E/Low-Density Lipoprotein Receptor-Deficient Mice: A Comparison with Nicotinic Acid.
    Mateuszuk L; Jasztal A; Maslak E; Gasior-Glogowska M; Baranska M; Sitek B; Kostogrys R; Zakrzewska A; Kij A; Walczak M; Chlopicki S
    J Pharmacol Exp Ther; 2016 Feb; 356(2):514-24. PubMed ID: 26631491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pravastatin polarizes the phenotype of macrophages toward M2 and elevates serum cholesterol levels in apolipoprotein E knockout mice.
    Zhang X; Xiao S; Li Q
    J Int Med Res; 2018 Aug; 46(8):3365-3373. PubMed ID: 30058421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice.
    Theelen TL; Lappalainen JP; Sluimer JC; Gurzeler E; Cleutjens JP; Gijbels MJ; Biessen EA; Daemen MJ; Alitalo K; Ylä-Herttuala S
    Atherosclerosis; 2015 Aug; 241(2):297-304. PubMed ID: 26062989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.